vitjВрач и информационные технологииMedical Doctor and Information Technologies1811-01932413-5208Pirogov National Medical and Surgical Center10.25881/18110193_2025_1_22vitj-93Research ArticleОБЗОРЫREVIEWSВозможности телемониторинга пациентов с гематологическими заболеваниями: нарративный обзорFeasibility of telemonitoring in hematology patients: a narrative reviewОсадчаяП. В.OsadchayaP. V.

Самара

Samara

p.v.osadchaya@samsmu.ruГаранинА. А.GaraninA. A.

к.м.н.

Самара

PhD

Samara

sameagle@yandex.ruДавыдкинИ. Л.DavydkinI. L.

д.м.н., профессор

Самара

DSc, Professor

Samara

i.l.davydkin@samsmu.ruФГБОУ ВО СамГМУ Минздрава РоссииРоссияFederal State Budgetary Educational Institution Samara State Medical University of the Russian Ministry of HealthRussian Federation202524032025012229Copyright © Осадчая П.В., Гаранин А.А., Давыдкин И.Л., 20252025Осадчая П.В., Гаранин А.А., Давыдкин И.Л.Osadchaya P.V., Garanin A.A., Davydkin I.L.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.vit-j.ru/jour/article/view/93

Анализу подвергнуты данные литературы, представленные в открытых медицинских источниках, об использовании возможностей телемедицины в гематологии. Телемедицинская поддержка представляет собой эффективный способ ведения и мониторинга пациентов с целью минимизации визитов в лечебные учреждения в тех случаях, когда этого можно избежать. Изучены опыт и перспективы данного вида взаимодействия с точки зрения удовлетворенности пациентов и эффективности мониторинга различных гематологических заболеваний. Несмотря на малое количество результатов с высокой доказательностью, проведенные исследования демонстрируют оптимистичную картину использования телемедицины в реальной клинической практике, что ведет к необходимости более масштабных и качественных исследований для внедрения различных форм телемониторинга в рутинное наблюдение за гематологическими пациентами.

Literature data presented in open medical sources on the use of telemedicine in hematology were analyzed. Telemedicine is an effective way to manage and monitor patients in order to minimize in-person hospital visits when this can be avoided. The experience and perspectives of this type of interaction in terms of patient satisfaction and effectiveness in monitoring various hematologic diseases have been studied. Despite the small number of results with high evidence, the studies demonstrate an optimistic picture of the use of telemedicine in real clinical practice, which leads to the need for more large-scale and high-quality studies to introduce various forms of telemonitoring in the routine follow-up of hematologic patients.

телемониторингтелемедицинаудаленное наблюдениемобильное приложениепортативное устройствогематологияtelemedicineeHealthDigital Healthremote patient monitoringmobile health deviceswearable device systemhematologymalignantnonmalignantpatient perspectiveReferencesMussetti A, Peric Z, Figueroa C. COVID19 in hematological patients and telemedicine: lessons learned across Europe and the US. Current Opinion in Infectious Diseases. 2022; 35(4): 295-01. doi: 10.1097/qco.0000000000000843.Mussetti A, Peric Z, Figueroa C. COVID19 in hematological patients and telemedicine: lessons learned across Europe and the US. Current Opinion in Infectious Diseases. 2022; 35(4): 295-01. doi: 10.1097/qco.0000000000000843.Шешунова Р.А. Формирование и развитие гематологической службы в России. Наука и инновации в медицине. – 2019. – Т. 4. – №1. – С.42-47.Sheshunova RA. Establishing and development of hematology service in Russia. Science and Innovations in Medicine. 2019; 4(1): 42-47. (In Russ.) doi: 10.35693/2500-1388-2019-4-1-42-47.Лукина К.А., Зайцев Д.А., Гармаева Т.Ц., Менделеева Л.П. Телемедицина как инструмент межрегионального дистанционного взаимодействия с профильными медицинскими организациями субъектов Российской Федерации: 5-летний опыт ФГБУ «НМИЦ гематологии» Минздрава России // Врач и информационные технологии. – 2020. – №4. – С.68-77.Lukina KA, Zaitsev DA, Garmaeva TC, Mendeleeva LP. Telemedicine as an instrument of interregional remote interaction with specialized medical organizations of the subjects of the Russian Federation: 5-year experience of the Federal State Budgetary Institution "NMIC of Hematology" of the Ministry of Health of the Russian Federation. Doctor and information technology. 2020; 4: 68-77. (In Russ.) doi: 10.37690/1811-0193-2020-4-68-77.Лагутин М.Д., Самофалов Д.А., Тюфилин Д.С., Чигрина В.П., Кильник А.И., Кобякова О.С. Тренды в оказании телемедицинских услуг ведущими федеральными центрами Российской Федерации. Социальные аспекты здоровья населения сетевое издание. – 2024. – Т.70. – №2. – С.1. Режим доступа: http://vestnik.mednet.ru/content/view/1581/27/lang,ru/.Lagutin MD, Samofalov DA, Tyufilin DS, Chigrina VP, Kilimnik AI, Kobyakova OS. In the trend of providing telemedicine services by federal centers of the Russian Federation. Social aspects of public health online edition. 2024; 70(2): 1. Achievement mode: http://vestnik.mednet.ru/content/view/1581/27/lang,ru/. (In Russ.) doi: 10.21045/2071-5021-2024-70-2-1.Иванова А.А., Завалева Е.В., Павлюк А.В., Новичкова Г.А. Возможности, проблемы и перспективы применения телемедицинских технологий в области детской онкогематологии // Вопросы гематологии/онкологии и иммунопатологии в педиатрии. – 2020. – Т.19. – №3. – С.189-193.Ivanova AA, Zavaleva EV, Pavlyuk AV, Novichkova GA. Possibilities, problems and prospects of application of telemedicine technologies in the field of pediatric hematology. Issues of hematology/oncology and immunopathology in pediatrics. 2020; 19(3): 189-193. (In Russ.) doi: 10.24287/1726-1708-2020-19-3-189-193.Федеральный закон от 21 ноября 2011 года №323-ФЗ «Об основах охраны здоровья граждан в Российской Федерации». Доступно по: https://minzdrav.gov.ru/documents/7025-federalnyy-zakon-ot-21-noyabrya-2011-g-323-fz-ob-osnovah-ohrany-zdorovya-grazhdan-v-rossiyskoy-federatsiiFederal’nyi zakon № 323-FZ ot 21 noyabrya 2011 goda «Ob osnovah ohrany zdorov'ya grazhdan v Rossijskoj Federacii». Available from: https://minzdrav.gov.ru/documents/7025-federalnyy-zakon-ot-21-noyabrya-2011-g-323-fz-ob-osnovah-ohrany-zdorovya-grazhdan-v-rossiyskoy-federatsii (In Russ.)Shah AC, O'Dwyer LC, Badawy SM. Telemedicine in Malignant and Nonmalignant Hematology: Systematic Review of Pediatric and Adult Studies. JMIR Mhealth Uhealth. 2021; 9(7): e29619. doi: 10.2196/29619.Shah AC, O'Dwyer LC, Badawy SM. Telemedicine in Malignant and Nonmalignant Hematology: Systematic Review of Pediatric and Adult Studies. JMIR Mhealth Uhealth. 2021; 9(7): e29619. doi: 10.2196/29619.Jacobsen M, Rottmann P, Dembek TA et al. Feasibility of Wearable-Based Remote Monitoring in Patients During Intensive Treatment for Aggressive Hematologic Malignancies. JCO Clinical Cancer Informatics. 2022; 6. doi: 10.1200/CCI.21.00126.Jacobsen M, Rottmann P, Dembek TA et al. Feasibility of Wearable-Based Remote Monitoring in Patients During Intensive Treatment for Aggressive Hematologic Malignancies. JCO Clinical Cancer Informatics. 2022; 6. doi: 10.1200/CCI.21.00126.Nawas MT, Landau HJ, Sauter CS et al. Pilot Study of Telehealth Evaluations in Patients Undergoing Hematopoietic Cell Transplantation. Biology of Blood and Marrow Transplantatio. 2020; 26(6): e135-7. doi: 10.1016/j.bbmt.2020.02.004.Nawas MT, Landau HJ, Sauter CS et al. Pilot Study of Telehealth Evaluations in Patients Undergoing Hematopoietic Cell Transplantation. Biology of Blood and Marrow Transplantatio. 2020; 26(6): e135-7. doi: 10.1016/j.bbmt.2020.02.004.Chang E, Iukuridze A, Echevarria M, et al. Feasibility and Acceptability of Using a Telehealth Platform to Monitor Cardiovascular Risk Factors in Hematopoietic Cell Transplantation Survivors at Risk for Cardiovascular Disease. Biology of Blood and Marrow Transplantation. 2020; 26(6): 1233-7. doi: 10.1016/j.bbmt.2020.02.027.Chang E, Iukuridze A, Echevarria M, et al. Feasibility and Acceptability of Using a Telehealth Platform to Monitor Cardiovascular Risk Factors in Hematopoietic Cell Transplantation Survivors at Risk for Cardiovascular Disease. Biology of Blood and Marrow Transplantation. 2020; 26(6): 1233-7. doi: 10.1016/j.bbmt.2020.02.027.Turner J, He Q, Baker K, et al. Home Spirometry Telemonitoring for Early Detection of Bronchiolitis Obliterans Syndrome in Patients with Chronic Graft-versus-Host Disease. Transplantation and Cellular Therapy. 2021; 27(7): 616.e1-616.e6. doi: 10.1016/j.jtct.2021.03.024.Turner J, He Q, Baker K, et al. Home Spirometry Telemonitoring for Early Detection of Bronchiolitis Obliterans Syndrome in Patients with Chronic Graft-versus-Host Disease. Transplantation and Cellular Therapy. 2021; 27(7): 616.e1-616.e6. doi: 10.1016/j.jtct.2021.03.024.Postorino M, Treglia M, Giammatteo J, et al. Telemedicine as a Medical Examination Tool During the Covid-19 Emergency: The Experience of the Onco-Haematology Center of Tor Vergata Hospital in Rome. Int J Environ Res Public Health. 2020; 17(23): 8834. doi: 10.3390/ijerph17238834.Postorino M, Treglia M, Giammatteo J, et al. Telemedicine as a Medical Examination Tool During the Covid-19 Emergency: The Experience of the Onco-Haematology Center of Tor Vergata Hospital in Rome. Int J Environ Res Public Health. 2020; 17(23): 8834. doi: 10.3390/ijerph17238834.Palandri F, Bartoletti D, Giaquinta S, et al. Telemedicine in patients with haematological diseases during the coronavirus disease 2019 (COVID-19) pandemic: selection criteria and patients’ satisfaction. British Journal of Haematology. 2020; 192(2). doi: 10.1111/bjh.17208.Palandri F, Bartoletti D, Giaquinta S, et al. Telemedicine in patients with haematological diseases during the coronavirus disease 2019 (COVID-19) pandemic: selection criteria and patients’ satisfaction. British Journal of Haematology. 2020; 192(2). doi: 10.1111/bjh.17208.Darcourt JG, Aparicio K, Dorsey PM et al. Analysis of the Implementation of Telehealth Visits for Care of Patients With Cancer in Houston During the COVID-19 Pandemic. JCO Oncology Practice. 2021; 17(1): e36-43. doi: 10.1200/op.20.00572.Darcourt JG, Aparicio K, Dorsey PM et al. Analysis of the Implementation of Telehealth Visits for Care of Patients With Cancer in Houston During the COVID-19 Pandemic. JCO Oncology Practice. 2021; 17(1): e36-43. doi: 10.1200/op.20.00572.Kumar P, Aggarwal M, Dhawan R, et al. Tele-Medicine Services in Hematological Practice During Covid Pandemic: Its Feasibility and Difficulties. Indian Journal of Hematology and Blood Transfusion. 2020; 37(4): 528-33. doi: 10.1007/s12288-020-01385-7.Kumar P, Aggarwal M, Dhawan R, et al. Tele-Medicine Services in Hematological Practice During Covid Pandemic: Its Feasibility and Difficulties. Indian Journal of Hematology and Blood Transfusion. 2020; 37(4): 528-33. doi: 10.1007/s12288-020-01385-7.Mussetti A, Salas MQ, Condom M, et al. Use of Telehealth for Domiciliary Follow-up After Hematopoietic Cell Transplantation During the COVID-19 Pandemic: Prospective Pilot Study. JMIR Formative Research. 2021; 5(3): e26121. doi: 10.2196/26121.Mussetti A, Salas MQ, Condom M, et al. Use of Telehealth for Domiciliary Follow-up After Hematopoietic Cell Transplantation During the COVID-19 Pandemic: Prospective Pilot Study. JMIR Formative Research. 2021; 5(3): e26121. doi: 10.2196/26121.Lupo-Stanghellini MT, Messina C, Marktel S, et al. Following-up allogeneic transplantation recipients during the COVID-19 pandemic. The Lancet Haematology. 2020; 7(8): e564-5. doi: 10.1016/s2352-3026(20)30176-9.Lupo-Stanghellini MT, Messina C, Marktel S, et al. Following-up allogeneic transplantation recipients during the COVID-19 pandemic. The Lancet Haematology. 2020; 7(8): e564-5. doi: 10.1016/s2352-3026(20)30176-9.Paludo J, Bansal R, Holland AT, et al. Pilot Implementation of Remote Patient Monitoring Program for Outpatient Management of CAR-T Cell Therapy. Blood. 2021; 138(S1): 568-568. doi: 10.1182/blood-2021-149103.Paludo J, Bansal R, Holland AT, et al. Pilot Implementation of Remote Patient Monitoring Program for Outpatient Management of CAR-T Cell Therapy. Blood. 2021; 138(S1): 568-568. doi: 10.1182/blood-2021-149103.

The authors declare that there are no conflicts of interest present.